Anixa Biosciences (ANIX)
(Delayed Data from NSDQ)
$2.98 USD
+0.01 (0.34%)
Updated May 14, 2024 04:00 PM ET
After-Market: $2.98 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 6/12/24 |
---|---|
Current Quarter | -0.11 |
EPS Last Quarter | -0.10 |
Last EPS Surprise | -11.11% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.44 |
Next Year | -0.45 |
EPS (TTM) | -0.34 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (10/2024) |
Next Year (10/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.21M | 0.00M | 0.21M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (10/2024) |
Next Year (10/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.11 | -0.11 | -0.44 | -0.45 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.11 | -0.11 | -0.44 | -0.45 |
High Estimate | -0.11 | -0.11 | -0.44 | -0.45 |
Low Estimate | -0.11 | -0.11 | -0.44 | -0.45 |
Year ago EPS | -0.07 | -0.08 | -0.32 | -0.44 |
Year over Year Growth Est. | -57.14% | -37.50% | -37.50% | -2.27% |
Agreement - Estimate Revisions
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (10/2024) |
Next Year (10/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (10/2024) |
Next Year (10/2025) |
|
---|---|---|---|---|
Current | -0.11 | -0.11 | -0.44 | -0.45 |
7 Days Ago | -0.11 | -0.11 | -0.44 | -0.45 |
30 Days Ago | -0.11 | -0.11 | -0.44 | -0.45 |
60 Days Ago | -0.09 | -0.09 | -0.37 | -0.40 |
90 Days Ago | -0.09 | -0.09 | -0.37 | -0.40 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (10/2024) |
Next Year (10/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.11 | -0.11 | -0.44 | -0.45 |
Zacks Consensus Estimate | -0.11 | -0.11 | -0.44 | -0.45 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (1/2024) |
Quarter Ending (10/2023) |
Quarter Ending (7/2023) |
Quarter Ending (4/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.10 | -0.09 | -0.08 | -0.07 | NA |
Estimate | -0.09 | -0.09 | -0.09 | -0.11 | NA |
Difference | -0.01 | 0.00 | 0.01 | 0.04 | 0.01 |
Surprise | -11.11% | 0.00% | 11.11% | 36.36% | 9.09% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more